结直肠癌患者术前血浆D-二聚体与临床病理特征之间的关系
The Relationship between Preoperative D-Dimer and Clinicopathological Characteristics in Patients with Colorectal Cancer
摘要: 目的:探究结直肠癌患者术前血浆D-二聚体水平与患者临床病理特征之间的关系。方法:收集115例我院于2022年1月至2024年12月经手术治疗的结直肠癌患者,根据D二聚体是否升高进行分组,结合患者临床病理特征,应用卡方检验分析患者D二聚体在不同临床病理特征之间是否存差异,应用Spearman相关分析探索D-二聚体水平与临床病理特征之间无相关性。结果:术后病理分期晚、存在淋巴结转移、脉管侵犯、肿瘤组织浸润肠壁深的患者往往存在D-二聚体异常升高,并且存在统计学差异(P < 0.05),而D-二聚体水平在不同肿瘤分化程度、有无神经侵犯中无显著差异。此外,肿瘤指标CA199、CEA异常与血浆D-二聚体水平具有相关性。结论:术前血浆D-二聚体与结直肠癌患者的病情存在密切相关性,临床中可通过检测血浆D-二聚体水平来综合评估患者预后。
Abstract: Objective: To explore the relationship between the pre-operative plasma D-dimer levels and the clinicopathological characteristics of patients with colorectal cancer. Methods: A total of 115 patients with colorectal cancer who underwent surgical treatment in our hospital from January 2022 to December 2024 were collected. The patients were grouped according to whether the D-dimer level was elevated. Combined with the clinicopathological characteristics of the patients, the chi-square test was used to analyze whether there were differences in D-dimer levels among different clinicopathological characteristics, and Spearman’s correlation analysis was applied to explore the correlation between D-dimer and clinicopathological characteristics. Result: Patients with late pathological staging, lymph node metastasis, vascular invasion, and deep tumor tissue invasion of the intestinal wall often had elevated D-dimer levels, and there were statistical differences (P < 0.05). However, there were no significant differences in D-dimer levels among patients with different degrees of differentiation and with or without never invasion. In addition, abnormal tumor markers CA199 and CEA were correlated with plasma D-dimer. Conclusion: Pre-operative plasma D-dimer levels are closely related to the state of an illness in patients with colorectal cancer. In clinical practice, plasma D-dimer levels can be detected to comprehensively evaluate the prognosis of patients.
文章引用:王梦雅, 赵维勇. 结直肠癌患者术前血浆D-二聚体与临床病理特征之间的关系[J]. 临床医学进展, 2025, 15(11): 2090-2095. https://doi.org/10.12677/acm.2025.15113323

参考文献

[1] Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A. (2023) Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17-48. [Google Scholar] [CrossRef] [PubMed]
[2] 向荣, 文家治. 不同术式治疗左侧结肠癌并发急性肠梗阻的临床效果及预后影响因素分析[J]. 临床误诊误治, 2024, 37(15): 25-29.
[3] Kangro, K., Wolberg, A.S. and Flick, M.J. (2022) Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19. Current Drug Targets, 23, 1593-1602.
[4] Komatsu, H., Shimada, M., Osaku, D., Deura, I., Sato, S., Oishi, T., et al. (2020) Deep Vein Thrombosis and Serum D-Dimer after Pelvic Lymphadenectomy in Gynecological Cancer. International Journal of Gynecological Cancer, 30, 860-864. [Google Scholar] [CrossRef] [PubMed]
[5] Li, Y., Cao, L., Liu, L., Ding, Y. and Cao, F. (2025) Peripheral Blood Markers Predict Prognosis and irAEs of Stage IV Driver Gene-Negative Lung Adenocarcinoma Treated with ICIs. Frontiers in Immunology, 16, Article 1538392. [Google Scholar] [CrossRef] [PubMed]
[6] Wu, B., Zhang, G., Zhao, X., Wang, J., Wang, D., Zhang, Y., et al. (2024) Association between D-Dimer Levels and Clinicopathological Characteristics of Pancreatic Cancer and Its Role in Prognosis: A Systematic Review and Meta-Analysis. Asian Journal of Surgery, 47, 3417-3424. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, X., Wang, X., Li, W., Sun, T., Dang, C. and Diao, D. (2022) D-Dimer, a Predictor of Bad Outcome in Gastric Cancer Patients Undergoing Radical Resection. Scientific Reports, 12, Article No. 16432. [Google Scholar] [CrossRef] [PubMed]
[8] Righini, M., Van Es, J., Den Exter, P.L., Roy, P., Verschuren, F., Ghuysen, A., et al. (2014) Age-Adjusted D-Dimer Cutoff Levels to Rule out Pulmonary Embolism: The ADJUST-PE Study. Journal of the American Medical Association, 311, 1117-1124. [Google Scholar] [CrossRef] [PubMed]
[9] Kruger, P.C., Eikelboom, J.W., Douketis, J.D. and Hankey, G.J. (2019) Deep Vein Thrombosis: Update on Diagnosis and Management. Medical Journal of Australia, 210, 516-524. [Google Scholar] [CrossRef] [PubMed]
[10] Jin, S., Qin, D., Liang, B., Zhang, L., Wei, X., Wang, Y., et al. (2022) Machine Learning Predicts Cancer-Associated Deep Vein Thrombosis Using Clinically Available Variables. International Journal of Medical Informatics, 161, Article 104733. [Google Scholar] [CrossRef] [PubMed]
[11] 陈春雨, 顾江魁, 周静, 等. 非小细胞肺癌患者术后静脉血栓风险预测模型的构建及验证[J]. 中国肿瘤临床, 2025, 52(7): 338-344.
[12] Mukai, M. and Oka, T. (2018) Mechanism and Management of Cancer-Associated Thrombosis. Journal of Cardiology, 72, 89-93. [Google Scholar] [CrossRef] [PubMed]
[13] Fernandes, C.J., Morinaga, L.T.K., Alves, J.L., Castro, M.A., Calderaro, D., Jardim, C.V.P., et al. (2019) Cancer-Associated Thrombosis: The When, How and Why. European Respiratory Review, 28, Article 180119. [Google Scholar] [CrossRef] [PubMed]
[14] Chen, Y., Yu, H., Wu, C., Li, J., Jiao, S., Hu, Y., et al. (2016) Prognostic Value of Plasma D-Dimer Levels in Patients with Small-Cell Lung Cancer. Biomedicine & Pharmacotherapy, 81, 210-217. [Google Scholar] [CrossRef] [PubMed]
[15] Alkhoder, L., Salamoon, M., Saifo, M. and Alwassouf, S. (2024) D-Dimer as a Predictive Biomarker of Response to Chemotherapy in Patients with Metastatic Breast Cancer. Biomarker Insights, 19, Article 865410096.
[16] 王芳, 齐亚鹏, 刘学艳, 等. 外周血NLR、CEA、D二聚体水平在胃癌根治术患者预后评估中的价值[J]. 实用癌症杂志, 2023, 38(5): 734-736.
[17] 黄莉, 邱梅英. 直肠癌根治术患者术前外周血D-二聚体水平检测的临床意义及预后预测价值[J]. 现代肿瘤医学, 2022, 30(11): 2012-2016.